Abstract Body

Background

Antiretroviral therapy (ART) use has been instrumental in controlling disease progression in people living with HIV-1. However, pervasive, replication competent viral reservoirs, established during the early stages of infection, rapidly initiate viral rebound following treatment interruption. Although long-lived, circulating memory T cells have traditionally been considered the primary HIV reservoir; emerging data suggest that a broader range of anatomical sites comprised of diverse HIV-susceptible cells contribute to reservoir maintenance. We hypothesize that tissue resident reservoirs within the gut actively produce infectious virus and are responsible for generating and sustaining the genetically diverse viral populations required to seed the rapid viremic rebound observed following analytical therapy interruption (ATI).

Methods

We employ a PET/CT based beacon guided necropsy approach in conjunction with our long-read full genome sequencing pipeline to interrogate the determinants of viral rebound initiation in difficult to probe infected tissues of SIV-infected rhesus macaques (RM). Four RM were infected intravenously with SIVmac239M2—a genetically barcoded SIVmac239 virus stock—and treated with ART for 49 weeks before ATI. Necropsies were performed one-week post-ATI. Whole blood and rectal biopsies were collected longitudinally. RM were injected with 64Cu-P7D3fab2 (anti SIV envelope) probe, allowing us to specifically target and collect rare hotspots of tissue associated pre-viremic replication during ART and after ATI guided by PET/CT imaging. Viral RNA and integrated proviral DNA was extracted from all samples, then replication kinetics and population dynamics were assessed using qPCR and near full genome long-read deep sequencing, respectively.

Results

Our phylogenetic analysis revealed biological diversification, including evidence of compartmentalization, viral population shifts, and events of convergent evolution within the SIV reservoirs under ART. Tissue-derived sequences after ATI demonstrated greater genetic diversity compared to those from parallel PBMC samples, with the highest degree of viral diversity found in the gut. Barcode analysis revealed fluctuations in the distributions of viral lineages, with a decline in proviral diversity in PBMCs while diversity was retained within the gut associated tissues. 

Conclusions

These data implicate that sources external to the blood retain viral diversity and act to seed the initial stages of viral rebound.